Minerva Neurosciences Inc (NERV) Down 4.94% in Premarket Trading

Minerva Neurosciences Inc (NERV) has fallen Monday morning, with the stock decreasing -4.94% in pre-market trading to 2.5. NERV's short-term technical score of 8 indicates that the stock has traded less bullishly over the last month than 92% of stocks on the market. In the Biotechnology industry, which ranks 86 out of 146 industries, the stock ranks higher than 12% of stocks. Minerva Neurosciences Inc has fallen 72.14% over the past month, closing at $10.79 on February 5. During this period of time, the stock fell as low as $2.63 and as high as $13.49. NERV has an average analyst recommendation of Sell. The company has an average price target of $11.00.

NERV has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on NERV!

See Full NERV Report

Minerva Neurosciences Inc has a Long-Term Technical rank of 25. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 75% of the market scoring higher. In the Biotechnology industry which is number 44 by this metric, NERV ranks better than 44% of stocks.

Important Dates for Investors in NERV:

-Minerva Neurosciences Inc is set to release earnings on 2024-05-22. Over the last 12 months, the company has reported EPS of $-4.67. -We do not have a set dividend date for Minerva Neurosciences Inc at this time. Click Here To Get The Full Report on Minerva Neurosciences Inc (NERV)